Evidence map›Paper›PMID 33489685›Full record

Article3 Biotech2021

Antibacterial and anticancer activity of ZnO with different morphologies: a comparative study.

S C Esparza González, Ena Bolaina-Lorenzo, J J Pérez-Trujillo, B A Puente-Urbina, O Rodríguez-Fernández, A Fonseca-García, R Betancourt-Galindo

Open access · greenAbstract read
In one paragraph

Article in 3 Biotech, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 67 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Biogenic Zinc oxide nanoparticles fromFrontiers in bioengineering and biotechnology · 2023
    Article
  17. Article
  18. Synthesis of M-AgInternational journal of molecular sciences · 2022
    Article
  19. Article
  20. Journal of fungi (Basel, Switzerland) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

S C Esparza GonzálezSchool of Dentistry, Saltillo Campus, Autonomous University of Coahuila, Adolfo Lopez Mateos, 25125 Saltillo, Coahuila Mexico.
Ena Bolaina-LorenzoCenter for Research in Applied Chemistry, Blvd. Enrique Reyna No. 140, Col. San José de Los Cerritos, 25294 Saltillo, Coahuila Mexico.
J J Pérez-TrujilloSchool of Medicine, Autonomous University of Nuevo Leon, 64460 San Nicolás de los Garza, Nuevo Leon Mexico.
B A Puente-UrbinaCenter for Research in Applied Chemistry, Blvd. Enrique Reyna No. 140, Col. San José de Los Cerritos, 25294 Saltillo, Coahuila Mexico.
O Rodríguez-FernándezCenter for Research in Applied Chemistry, Blvd. Enrique Reyna No. 140, Col. San José de Los Cerritos, 25294 Saltillo, Coahuila Mexico.
A Fonseca-GarcíaConsejo Nacional de Ciencia y Tecnología (CONACYT)-Centro de Investigación en Química Aplicada (CIQA), Blvd. Enrique Reyna Hermosillo 140, 25294 Saltillo, Coahuila Mexico.
R Betancourt-GalindoCenter for Research in Applied Chemistry, Blvd. Enrique Reyna No. 140, Col. San José de Los Cerritos, 25294 Saltillo, Coahuila Mexico.
Consejo Nacional de Humanidades, Ciencias y Tecnologías · MXUniversidad Autónoma de Coahuila · MXUniversidad Autónoma de Nuevo León · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

ZnO nanoparticles (NPS) with different morphologies were synthesized, and the antibacterial and anticancer activity was studied, herein. The physicochemical characterization was carried out by X-ray diffraction (XRD), transmission electron microscopy (TEM), Fourier-transform infrared spectroscopy (FTIR) and UV-visible. To study the antibacterial and anticancer capability of ZnO NPS,

Indexed as

Bacterial growth inhibitionDNA damageHeLa cells viabilityZnO NPS

Identifiers

PMID33489685
PMCPMC7806688
OpenAlexW3119326264

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.